Key points are not available for this paper at this time.
We compared the expression of CD123, the alpha chain of the interleukin-3 receptor, on normal B-cell precursors in bone marrow ("hematogones") from 75 specimens and on leukemic blasts in 45 newly diagnosed B-acute lymphoblastic leukemias (B-ALL) cases. We found that the less mature hematogones (dim CD45+) that express CD34 lack CD123 expression, whereas the more mature hematogones (moderate CD45+) lack CD34 but always express CD123. In contrast with this discordant pattern of CD34 and CD123 expression in hematogones, blasts in 41 (91%) of 45 cases of B-ALL showed concordant expression of the 2 antigens: 80% (36 of 45) cases expressed both antigens, whereas 11% (5 of 45) expressed neither. We found that these distinct patterns of CD34/CD123 expression on hematogones (discordant) and B-ALL blasts (concordant) remain stable after chemotherapy and are useful in differentiating small populations of residual blasts from hematogones that may be simultaneously present.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hassanein et al. (Thu,) studied this question.
synapsesocial.com/papers/69df4be8d5404a0bea592d9d — DOI: https://doi.org/10.1309/ajcpo4ds0gtlsoei
Nagwa Hassanein
Al-Azhar University
Felisa Alcancia
Kathryn Perkinson
Duke Medical Center
American Journal of Clinical Pathology
Duke Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: